Literature DB >> 17310984

Phorbol esters inhibit the Hedgehog signalling pathway downstream of Suppressor of Fused, but upstream of Gli.

M Lauth1, A Bergström, R Toftgård.   

Abstract

The developmentally important Hedgehog (Hh) signal transduction pathway, which has recently been implicated in several forms of cancer, is subject to regulation by several protein kinases. Here, we address the role of protein kinase Cdelta in pathway inhibition and show that cellular depletion or pharmacological inhibition of this kinase isoform results in a blockade of signalling between Suppressor of Fused and the Gli transcription factors. We further provide evidence that the observed pathway inhibition is independent of primary cilia and the mitogen-activated protein kinase kinase (Mek1) kinase. These findings allowed for the rapid dissection of downstream Hh pathway activation mechanisms in human tumour cells and demonstrate a surprising variation in how cells can activate signalling in a ligand- and receptor-independent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310984     DOI: 10.1038/sj.onc.1210321

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Ulrica Tostar; Qianren Jin; Volker Fendrich; Carmen Guerra; Mariano Barbacid; Rune Toftgård
Journal:  Nat Struct Mol Biol       Date:  2010-05-30       Impact factor: 15.369

2.  Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.

Authors:  Jun Zhao; Chunhui Wu; James Abbruzzese; Rosa F Hwang; Chun Li
Journal:  Mol Pharm       Date:  2015-05-12       Impact factor: 4.939

3.  Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Authors:  Frederic Bassilana; Adam Carlson; Jennifer A DaSilva; Bianka Grosshans; Solange Vidal; Valerie Beck; Barbara Wilmeringwetter; Luis A Llamas; Todd B Showalter; Pascal Rigollier; Aaron Bourret; Arun Ramamurthy; Xu Wu; Fred Harbinski; Samantha Plonsky; Lac Lee; Heinz Ruffner; Paola Grandi; Markus Schirle; Jeremy Jenkins; Andreas W Sailer; Tewis Bouwmeester; Jeffrey A Porter; Vic Myer; Peter M Finan; John A Tallarico; Joseph F Kelleher; Klaus Seuwen; Rishi K Jain; Sarah J Luchansky
Journal:  Nat Chem Biol       Date:  2014-03-16       Impact factor: 15.040

4.  Cleft lip and palate results from Hedgehog signaling antagonism in the mouse: Phenotypic characterization and clinical implications.

Authors:  Robert J Lipinski; Chihwa Song; Kathleen K Sulik; Joshua L Everson; Jerry J Gipp; Dong Yan; Wade Bushman; Ian J Rowland
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-04

5.  Probing seco-steroid inhibition of the hedgehog signaling pathway.

Authors:  Evrett N Thompson; Vibhavari Sail; Daniel S Raccuia; M Kyle Hadden
Journal:  Mol Cell Biochem       Date:  2018-06-06       Impact factor: 3.396

Review 6.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

7.  Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma.

Authors:  B A Emmenegger; E I Hwang; C Moore; S L Markant; S N Brun; J W Dutton; T-A Read; M P Fogarty; A R Singh; D L Durden; C Yang; W L McKeehan; R J Wechsler-Reya
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

Review 8.  Hedgehog-Gli signaling pathway inhibitors as anticancer agents.

Authors:  Neeraj Mahindroo; Chandanamali Punchihewa; Naoaki Fujii
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

Review 9.  The Gli code: an information nexus regulating cell fate, stemness and cancer.

Authors:  Ariel Ruiz i Altaba; Christophe Mas; Barbara Stecca
Journal:  Trends Cell Biol       Date:  2007-09-12       Impact factor: 20.808

10.  GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors.

Authors:  Jay Joo; Laura Christensen; Kegan Warner; Leith States; Hyung-Gyoo Kang; Kieuhoa Vo; Elizabeth R Lawlor; William A May
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.